While in a PARP1 knockout transgenic prostate adenocarcinoma mouse model, impaired PARP-1 function increased levels of transforming growth factor-β (TGF-β) and promoted prostate tumorigenesis in vivo via TGF-β-induced EMT 44. This evidence concerns the gene PARP1 and urogenital neoplasm.